Step up regulation

1. At a Glance

• Refers to the need to tighten quality regulation of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, Homoeopathy) medical education, amid rapid private-sector-led expansion of colleges [4].
• Private/non-government institutions dominate AYUSH education — 86% of Ayurveda colleges and 85% of homoeopathy colleges in 2024 [4].
• Quality deficits (faculty shortfalls, inadequate hospital infrastructure) are not new — flagged by CAG as early as 2005 — showing regulatory enforcement has lagged expansion [4].
• Relevant for UPSC as it links health governance, federalism in medical education regulation, and the National Commission for Indian System of Medicine (NCISM) as a statutory regulator [1].

2. Why in the News

• A September 2026 editorial/analysis (The Hindu Business Line, 1 September 2026) highlighted the surge in AYUSH college seats and funding alongside persistent quality concerns, calling for stronger regulatory compliance [4].
• Data cited: permitted seats rose 43% and total admission capacity rose 25% between 2021 and 2024; Centre's AYURGYAN allocation for AYUSH education/training/research/innovation rose nearly sixfold in the same period [4].

3. Background & Evolution

• NCISM (National Commission for Indian System of Medicine) was constituted under the NCISM Act, 2020, established on 11 July 2021, replacing the earlier Central Council of Indian Medicine (CCIM) on 11 June 2021 [1].
• NCISM operates under the Ministry of Ayush, headquartered in New Delhi [1].
• The AYURGYAN Scheme (Central Sector Scheme) has been run by the Ministry of Ayush since FY 2021-22, approved for the period FY 2021-22 to FY 2025-26 [2].
• AYURGYAN has three components: (i) Capacity Building & Continuing Medical Education (CME); (ii) Research & Innovation in AYUSH; (iii) Ayurveda Biology Integrated Health Research (ABIHR), added from 2023-24 [2].
• Predecessor quality concerns: a 2005 CAG audit found insufficient hospital beds, outpatient services, and staff widespread among homoeopathy colleges, with bed occupancy ranging from 1% to 71% [4].
• A 2020 Journal of Ayurveda and Integrative Medicine study found many institutions had a teaching-staff shortfall exceeding 50% of prescribed standards [4].

4. Core Static Facts

Item	Detail
Regulator	National Commission for Indian System of Medicine (NCISM) [1]
Enabling law	NCISM Act, 2020 [1]
Established	11 July 2021 (replaced CCIM, dissolved 11 June 2021) [1]
Parent ministry	Ministry of Ayush [1]
Sub-bodies	Board of Ayurveda and Unani; Board of Unani, Siddha and Sowa-Rigpa; Board of Assessment and Rating; Board of Ethics and Registration [1]
Relevant scheme	AYURGYAN — Central Sector Scheme, FY 2021-22 to FY 2025-26 [2]
Private-sector share (2024)	86% of Ayurveda colleges; 85% of homoeopathy colleges [4]
Seat growth (2021-24)	Permitted seats +43%; total admission capacity +25% [4]
Funding growth	AYURGYAN allocation ~6x increase (2021-2024) [4]
Historical CAG finding	2005 audit — bed occupancy 1%-71% in homoeopathy colleges [4]

5. Multi-Dimensional Analysis

Social

• Rapid, private-led expansion risks producing underqualified AYUSH practitioners, affecting public trust in traditional medicine systems used widely in rural/semi-urban India [4].

Legal/Constitutional

• Regulatory teeth exist: NCISM has withheld or denied permission to institutions found deficient in faculty/infrastructure post-inspection, indicating an operative (if reactive) regulatory mechanism under the NCISM Act, 2020 [1][4].

Administrative/Governance

• Persistent implementation gap: quality issues identified by CAG in 2005 recur in a 2020 academic study, suggesting weak follow-through despite a dedicated regulator [4].
• Private institutions have financial incentives to expand enrolment that may not align with pedagogical/clinical infrastructure readiness [4].

Economic

• Government funding (AYURGYAN, ~6x rise) is scaling faster than demonstrated quality assurance, raising value-for-money and outcome-accountability questions [2][4].

Ethical/Governance

• Tension between allopathic-education concerns (evidence-based practice adequacy) versus AYUSH-education concerns (both training quality and validity of what is taught) — a distinct ethical dimension for AYUSH regulation [4].

6. Recent Developments (last 12-18 months)

• Ministry of Ayush continued AYURGYAN disbursals under its FY2021-22–FY2025-26 window, with allocations rising sharply through 2024 [2].
• NCISM marked its 4th Foundation Day around July 2025, per PIB releases tracking the Commission's institutional activities [1].
• Media commentary (1 September 2026) renewed scrutiny of the private-sector-led AYUSH college boom versus quality-control capacity [4].

7. Prelims Hooks

• NCISM was established on 11 July 2021 under the NCISM Act, 2020 [1].
• NCISM replaced the Central Council of Indian Medicine (CCIM), which was dissolved on 11 June 2021 [1].
• NCISM functions under the Ministry of Ayush (not Ministry of Health & Family Welfare) [1].
• NCISM has two key boards: Board of Assessment and Rating and Board of Ethics and Registration [1].
• AYUSH systems regulated under NCISM: Ayurveda, Unani, Siddha, Sowa-Rigpa (Homoeopathy is regulated separately by the National Commission for Homoeopathy) [1].
• AYURGYAN Scheme — Central Sector Scheme of the Ministry of Ayush, running FY 2021-22 to FY 2025-26 [2].
• AYURGYAN's third component, Ayurveda Biology Integrated Health Research (ABIHR), was added in 2023-24 [2].
• Non-government institutions accounted for 86% of Ayurveda and 85% of homoeopathy colleges in 2024 [4].
• Permitted seats in AYUSH colleges rose 43% (2021-2024); admission capacity rose 25% [4].
• A 2005 CAG audit found homoeopathy college bed occupancy ranging from 1% to 71% [4].
• A 2020 study in the Journal of Ayurveda and Integrative Medicine found teaching-staff shortfalls exceeding 50% of required norms in many institutions [4].

8. Mains Relevance

• GS-II: Health — Issues relating to development and management of Social Sector/Services relating to Health, Education; Statutory/regulatory bodies.
• GS-III: Indigenous technology/traditional knowledge systems (AYUSH), Growth & Development.
• Possible question stems: 1. "Discuss the challenges of ensuring quality control in India's rapidly expanding AYUSH medical education sector. Suggest reforms." (GS-II) 2. "Examine the role and effectiveness of statutory regulators like NCISM in balancing expansion of medical education with quality assurance." (GS-II) 3. "Private sector dominance in professional education often creates a trade-off between access and quality. Discuss in the context of AYUSH education in India." (GS-II/GS-III)

9. Related Topics to Study Next

• National Medical Commission (NMC) & NEET-PG/UG regulation — comparative allopathic regulatory model.
• National Commission for Homoeopathy (NCH) — parallel regulator for homoeopathy, distinct from NCISM.
• National AYUSH Mission (NAM) — the broader centrally sponsored scheme for AYUSH infrastructure.
• Private sector in higher/professional education — general regulatory-capture and quality debates.
• CAG audit mechanism & performance audits of ministries — institutional accountability angle.
• Traditional medicine & WHO Global Centre for Traditional Medicine (Jamnagar) — international dimension of AYUSH.
• Right to Health / patient safety jurisprudence — implications of under-trained practitioners.

10. Common Errors / Trap Areas

• Confusing NCISM (Ayurveda, Unani, Siddha, Sowa-Rigpa) with National Commission for Homoeopathy (NCH) — they are separate statutory bodies.
• Assuming AYUSH regulation falls under Ministry of Health & Family Welfare — it is under the standalone Ministry of Ayush.
• Mixing up NCISM (2020 Act, 2021 formation) with its predecessor Central Council of Indian Medicine (CCIM), established much earlier under the Indian Medicine Central Council Act, 1970.
• Conflating AYURGYAN (education/research capacity-building scheme) with National AYUSH Mission (NAM) (broader infrastructure/state-support scheme) — different scope and objectives.
• Treating AYUSH quality issues as a new phenomenon — CAG flagged them as far back as 2005, predating the recent private-sector expansion boom.